LC-MS/MS improves screening towards 21-hydroxylase deficiency

References

• Carmina E, Rosato F, Janni A, et al. Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 2006;91:2–6
   PubMed Web of Science ®Google Scholar
• Yildiz BO. Diagnosis of hyperandrogenism: clinical criteria. Best Pract Res Clin Endocrinol Metab 2006;20:167–76
   PubMed Web of Science ®Google Scholar
• Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223–36
   PubMed Web of Science ®Google Scholar
• Azziz R, Sanchez A, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004;89:453–62
   PubMed Web of Science ®Google Scholar
• AACE Hyperandrogenism Guidelines. Endocr Pract 2001;7:120–33
   Google Scholar
• Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010;95:4133–60
   PubMed Web of Science ®Google Scholar
• Ambroziak U, Bednarczuk T, Ginalska-Malinowska M, et al. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency-management in adults. Endokrynol Pol 2010;61:142–55
   PubMedGoogle Scholar
• New MI. Nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 2006;91:4205–14
   PubMed Web of Science ®Google Scholar
• Azziz R, Hincapie LA, Knochenhauer ES, et al. Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril 1999;72:915–25
   PubMed Web of Science ®Google Scholar
• Stanczyk FZ, Clarke NJ. Advantages and challenges of mass spectrometry assays for steroid hormones. J Steroid Biochem Mol Biol 2010;121:491–5
   PubMed Web of Science ®Google Scholar
• Honour JW. 17-Hydroxyprogesterone in children, adolescents and adults. Ann Clin Biochem 2014;51:424–40
   PubMed Web of Science ®Google Scholar
• Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440–7
   PubMed Web of Science ®Google Scholar
• Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008;93:1526–40
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, Sanchón R, San Millán JL. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab 2008;93:527–33
   PubMed Web of Science ®Google Scholar
• Koal T, Schmiederer D, Pham-Tuan H, et al. Standardized LC–MS/MS based steroid hormone profile-analysis. J Steroid Biochem Mol Biol 2012;129:129–38
   PubMed Web of Science ®Google Scholar
• Małunowicz EM, Mitkowska Z, Bal K, et al. Definitive diagnosis of enzymatic deficiencies of steroidogenesis in at-risk newborns and infants by urinary marker analysis using GC-MS/SIM. Horm Res 1997;48:243–51
   PubMedGoogle Scholar
• Miller SA, Dyke DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–7
   PubMedGoogle Scholar
• Carmina E, Longo RA, Rini GB, Lobo RA. Phenotypic variation in hyperandrogenic women influences the finding of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 2005;90:2545–9
   PubMed Web of Science ®Google Scholar
• Fanelli F, Belluomo I, Di Lallo VD, et al. Serum steroid profiling by isotopic dilution-liquid chromatography-mass spectrometry: comparison with current immunoassays and reference intervals in healthy adults. Steroids 2011;76:244–53
   PubMed Web of Science ®Google Scholar
• Soldin SJ, Soldin OP. Steroid hormone analysis by tandem mass spectrometry. Clin Chem 2009;55:1061–6
   PubMed Web of Science ®Google Scholar
• Janzen N, Peter M, Sander S, et al. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 2007;92:2581–9
   PubMed Web of Science ®Google Scholar
• Rossi C, Calton L, Hammond G, et al. Serum steroid profiling for congenital adrenal hyperplasia using liquid chromatography-tandem mass spectrometry. Clin Chim Acta 2010;411:222–8
   PubMed Web of Science ®Google Scholar
• Speiser PW. Improving neonatal screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 2004;89:3685–6
   PubMedGoogle Scholar
• Etter ML, Eichhorst J, Lehotay DC. Clinical determination of 17-hydroxyprogesterone in serum by LC-MS/MS: comparison to Coat-A-Count RIA method. J Chromatogr B Analyt Technol Biomed Life Sci 2006;840:69–74
   PubMedGoogle Scholar
• Janse F, Eijkemans MJ, Goverde AJ, et al. Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results. Eur J Endocrinol 2011;165:925–33
   PubMed Web of Science ®Google Scholar
• Keefe CC, Goldman MM, Zhang K, et al. Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry. PLoS One 2014;9:93805
   PubMedGoogle Scholar
• Handelsman DJ, Wartofsky L. Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism. J Clin Endocrinol Metab 2013;98:3971–3
   PubMed Web of Science ®Google Scholar